A. Neutropenia B. Diarrhea C. Liver toxicity (increase in aspartate aminotransferase [AST]/alanine aminotransferase [ALT]) D. Renal toxicity (increase in serum creatinine [SCr]) E. Unsure

A. Recognize that timing of toxicity correlates with drug administration and that treatment likely requires a different kind of management than cytotoxic chemotherapy (e.g., corticosteroids) B. Identify one member of the team who will handle all the immunotherapy toxicity questions and treatment C. Education of the entire team to improve communication with patients and their caregivers regarding adverse events from treatment D. Understand that proper dosing will minimize the likelihood of toxicity E. Unsure